Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis

M. Tanaka, M. Arita, H. Tachibana, T. Ishida, T. Nakazawa (Kurashiki, Japan)

Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Session: Diffuse parenchymal lung disease III
Session type: Thematic Poster Session
Number: 3810
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tanaka, M. Arita, H. Tachibana, T. Ishida, T. Nakazawa (Kurashiki, Japan). Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis. Eur Respir J 2013; 42: Suppl. 57, 3810

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Clinical features of interstitial lung disease in polymyositis and dermatomyositis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012


Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014


Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Interstitial lung diseases associated with amyopathic dermatomyositis
Source: Eur Respir J 2006; 28: 1005-1012
Year: 2006



Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011


Usefulness of skeletal muscle MRI in the diagnosis of polymyositis initially presenting with interstitial lung disease (ILD)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Source: Eur Respir J 2003; 22: 245-250
Year: 2003